TWiV 780: COVID-19 clinical update #71 with Dr. Daniel Griffin
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In COVID-19 clinical update #71, Daniel Griffin reviews updated school and child care guidance from CDC, transmission in schools, accuracy of lateral flow assays, update to J&J/Janssen vaccine EUA to include GBS, interim immunogenicity of Ad.26.CoV2.s, effectiveness of mRNA vaccines to prevent hospitalization, Bamlanivimab plus Etesevimab for mild or moderate disease, and a meta-analysis of ivermectin results.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- School and child care guidance (CDC)
- Transmission in schools (CDC)
- Accuracy of lateral flow diagnostics (Lancet)
- GBS with Ad.26.CoV2.s vaccine (FDA)
- Ad.26.CoV2.s interim immunogenicity (NEJM)
- mRNA vaccine effectiveness to prevent hospitalization (medRxiv)
- Bamlanivimab plus Etesevimab (NEJM)
- Meta-analysis of ivermectin studies (Clin Inf Dis)
- Letters read on TWiV 780
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]